These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 81854)

  • 1. Tumor-associated antigens of rat moloney sarcoma cells. I. Cell-surface antigens.
    Leung K; Jones JM; Feldman JD
    J Immunol; 1978 Nov; 121(5):1836-43. PubMed ID: 81854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated antigens of rat moloney sarcoma cells. II. Cytosol antigens.
    Leung K; Feldman JD
    J Immunol; 1978 Nov; 121(5):1844-8. PubMed ID: 309482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.
    Jiang D; Flyer DC
    J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma.
    Fernandez-Cruz E; Halliburton B; Feldman JD
    J Immunol; 1979 Oct; 123(4):1772-7. PubMed ID: 158055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topographical distribution and association of tumor--associated antigens and their role in antigenicity in rat tumor cells.
    Moriuchi T
    Hokkaido Igaku Zasshi; 1979 Sep; 54(5):487-99. PubMed ID: 93561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of macrophages and antibodies on in vivo growth of Moloney sarcoma in the rat.
    Miller GA; Feldman JD
    J Immunol; 1977 Oct; 119(4):1445-51. PubMed ID: 302284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented immunogenicity of tumor cell membranes produced by infection with influenza virus as compared to Moloney sarcoma virus.
    Takeichi N; Austin FC; Oikawa T; Boone CW
    Cancer Res; 1978 Dec; 38(12):4580-4. PubMed ID: 214226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations on the aminoacid content of tumor associated antigens of rat sarcoma cells induced by virus.
    Alexandrov I; Wesselinova D; Alexandrova R
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):147-54. PubMed ID: 10738910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of effective immunity to Moloney murine sarcoma virus using monoclonal anti-idiotypic antibody as immunogen.
    Powell TJ; Spann R; Nguyenduc M; Lamon EW
    J Immunol; 1989 Feb; 142(4):1318-24. PubMed ID: 2536772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.
    Biasi G; Saggin L; Dazzi F; De Rossi A; Collavo D
    J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
    Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
    J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M; Pearson G; Redmon L; Winters E; Kasuga S
    J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes with antiglobulin activity in sera of Moloney sarcoma-bearing rats.
    Balint JR
    Clin Exp Immunol; 1982 Apr; 48(1):70-8. PubMed ID: 6979450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential quantitation of circulating immune complexes in syngeneic and allogeneic rats bearing Moloney sarcomas.
    Jennette JC; Feldman JD
    J Immunol; 1977 Jun; 118(6):2269-74. PubMed ID: 301157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moloney virus-induced cell surface antigens and histocompatibility antigens are located on distinct molecules.
    Fox RI; Weissman IL
    J Immunol; 1979 May; 122(5):1697-704. PubMed ID: 87439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.